Project Grant HT94252410132
- Federal Grant Award Summary The University of Colorado-Denver received a $2.87 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period September 1, 2025, through August 31, 2029. The award supports research to evaluate the Clinical, Biomarkers, Imaging, and Modifiers (CBI-M) classification system for traumatic brain injury (TBI). This research initiative aims to advance clinical assessment and...
- The University of Colorado was awarded a $577,680.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support research to target EHMT1/2 to overcome therapy-resistant ovarian cancer. The project aims to transform healthcare for military service members, veterans, and the broader public by developing novel diagnostic tools, therapeutic interventions, and clinical practice guidelines to address critical health...
- The U.S. Defense Health Agency has awarded a $499,998 Project Grant to the University of Colorado-Denver under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, with a performance period from November 1, 2024 to October 31, 2026, is for developing a preservation method for vascularized composite allotransplantation (VCA) during static cold storage. This research aims to transform healthcare for military service members and the broader public by...
- This $1,599,997.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of Illinois aimed at transforming healthcare for military service members, veterans, and the broader public. The research, spanning basic, applied, and translational investigations, focuses on innovative approaches to address critical health challenges across diverse medical domains such as cancer,...
- This federal Project Grant award in the amount of $624,000.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Colorado-Denver. The grant will fund a 2-year project from July 1, 2024 to June 30, 2026 to investigate the use of cell-free DNA to define MYC activity in osteosarcoma. The University of Colorado-Denver, a major public research institution, will serve as the primary awardee and perform the research...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded the University of Colorado-Denver a $1.23M Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025, through August 31, 2028. The award funds the development of a fully automated deep learning-based framework for segmentation and treatment response assessment of lesions on PSMA (prostate-specific membrane antigen) PET/CT imaging in prostate cancer patients. This research...
- Federal Grant Award Summary The Defense Health Agency awarded a $599,140 Project Grant to The Regents of the University of Colorado (University of Colorado-Denver) under the Military Medical Research and Development program (CFDA 12.420) to support the US Precision Medicine Adaptive Network Platform Trial in Hypoxemic Acute Respiratory Failure (US-PANTHER). The award, effective September 1, 2025, with a completion date of August 31, 2030, funds a five-year clinical research initiative aimed at...
- The federal Project Grant award in the amount of $999,793.00 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). This award is supporting research by the Regents of the University of Colorado, specifically the University of Colorado Office of Contracts and Grants Division, to conduct targeted suppression of rodent models for multiple sclerosis (MS). The grant aims to deliver fundamental research and develop specialized data...
- The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $2,200,000 Project Grant to The Regents of the University of Colorado, doing business as the University of Colorado-Denver. The award, with an effective date of Sep 30, 2023 and ultimate completion date of Sep 29, 2026, will fund research focused on "Prevention and Treatment of Frostbite Infection with Antimicrobial Pharmacokinetic Analysis" to be conducted at the University's...
- The Defense Health Agency awarded a $390,000 Project Grant to the Sanford Burnham Prebys Medical Discovery Institute to support research using systems genetics to probe for gene interactions in congenital heart disease. The two-year award, made under the Military Medical Research and Development program (CFDA 12.420), will fund work from February 2021 through August 2023. The Military Medical Research and Development program aims to transform military and public health through innovative...
This $2,488,002.00 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports a multi-year research effort by the University of Colorado-Denver to develop biomarkers for detecting acute, subacute, and chronic organ injury following neonatal congenital heart disease surgery. The research aims to improve diagnostic capabilities and treatment outcomes for this patient population. The award runs from April 1, 2024 to March 31, 2028, and the University of Colorado-Denver may utilize subcontractors or subgrantees to execute various components of the research project. The Military Medical Research and Development program funds biomedical innovations with high potential impact on the health and care of military service members, veterans, and their families.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $2.5m | 2/20/24 |